VIVO
TECHNOLOGYMeridian Bioscience Inc
$3.11-0.20 (-6.04%)PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving VIVO Today?
No stock-specific AI insight has been generated for VIVO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.20$8.88
$3.11
Fundamentals
Market Cap$52M
P/E Ratio—
EPS$-2.17
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume638K
Avg Volume (10D)—
Shares Outstanding16.8M
VIVO News
18 articles- Presenting on Emerging Growth Conference 92 Day 1 on May 6; Register to live streamYahoo Finance·May 5, 2026
- VivoPower to Present at the Emerging Growth ConferenceYahoo Finance·Apr 29, 2026
- VivoPower secures $1.9M EBITDA boost From Norway grid flexibility marketsProactive Investors·Apr 27, 2026
- VivoPower Targets $1.9 Million Annualized EBITDA Uplift from Enrollment of Norway Data Center into Statnett Reserve Markets Demand Response ProgramYahoo Finance·Apr 27, 2026
- VivoPower launches tenant search for Norwegian data center after acquisitionProactive Investors·Apr 23, 2026
- VivoPower Launches Lease Bidding after Receiving Strong Interest from AI Operators for 41.5MW Norway Data CenterGlobeNewswire Inc.·Apr 23, 2026
- VivoPower turns EBITDA-profitable after closing $41M Norway data center dealProactive Investors·Apr 21, 2026
- VivoPower Becomes EBITDA Profitable: $31 Million Revenue, $10 Million EBITDA From Completion of Norway Data Center AcquisitionYahoo Finance·Apr 21, 2026
- VivoPower on why Nordics lead in AI infrastructure shiftYahoo Finance·Apr 15, 2026
- Adam Back's Satoshi rebuttal leaves key questions unansweredProactive Investors·Apr 11, 2026
- VivoPower appoints former Microsoft AI leader to advisory councilProactive Investors·Apr 7, 2026
- VivoPower Appoints Former Microsoft Global AI Business Leader and G42 Executive, Khadija Mustafa, to Advisory CouncilYahoo Finance·Apr 7, 2026
- VivoPower secures Nasdaq ticker for planned Tembo listingProactive Investors·Mar 26, 2026
- VivoPower begins share conversion program to reduce public float, bolster long-term alignmentProactive Investors·Mar 20, 2026
- VivoPower Commences Strategic Share Conversion Program; Initial 2.96 Million Listed Class A Ordinary Shares Becoming Unlisted Restricted Class B Shares, Reducing Public FloatYahoo Finance·Mar 20, 2026
- VivoPower shares jump as it terminates $180M F-3 registration statementProactive Investors·Mar 18, 2026
- VivoPower Terminates $180 Million F-3 Registration StatementYahoo Finance·Mar 18, 2026
- Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay PortfolioYahoo Finance·Feb 24, 2026
All 18 articles loaded
Price Data
Open$0.00
Previous Close$3.31
Day High$0.00
Day Low$0.00
52 Week High$8.88
52 Week Low$1.20
52-Week Range
$1.20$8.88
$3.11
Fundamentals
Market Cap$52M
P/E Ratio—
EPS$-2.17
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume638K
Avg Volume (10D)—
Shares Outstanding16.8M
About Meridian Bioscience Inc
Meridian Bioscience, Inc., a life sciences company, develops, manufactures, distributes and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels worldwide. The company is headquartered in Cincinnati, Ohio.
TECHNOLOGYSOFTWARE - INFRASTRUCTURE
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICSOFTWARE - INFRASTRUCTURE
CIK—
Composite FIGI—
Share Class FIGI—